CDSCO orders action against unapproved enclomiphene drugs
State authorities must immediately trace manufacturers, marketers, distributors, and retailers dealing in unapproved enclomiphene products, initiate regulatory action, and ensure these items are not manufactured or sold within their jurisdictions.
The Central Drugs Standard Control Organisation (CDSCO) has taken action against unapproved enclomiphene drugs, instructing state and Union territory drug controllers to prevent the manufacture, sale, or distribution of such medicines, according to government sources and a reviewed communication by Mint.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
